Literature DB >> 11945082

Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies.

S D Sivasubramaniam1, C C Finch, M A Billett, P N Baker, E E Billett.   

Abstract

A feature of pre-eclampsia is that circulating levels of maternal serotonin (5-hydroxytryptamine) are elevated and placental monoamine oxidase-A (MAO-A) activity, the major factor in the regulation of serotonin levels in pregnancy, is reduced. It is not known whether this is due to a reduced MAO-A protein content or a reduced catalytic turnover of the serotonin by MAO-A; this question has been addressed in the present work. Term placentae from normotensive and pre-eclamptic women were analysed for MAO-A specific mRNA expression (by semi-quantitative RT-PCR), MAO-A protein (by immunohistochemistry and quantitative ELISA, using a MAO-A specific monoclonal antibody), together with MAO activity (using [(3)H] labelled 5-hydroxytryptamine as substrate). Immunohistochemical analysis of placentae from both normotensive and pre-eclamptic women demonstrated that MAO-A protein is located in the cytoplasm of the placental syncytiotrophoblast layer, consistent with a mitochondrial location; no MAO-A protein was found in the nucleus. No MAO-B protein was detected in this placental layer, despite the presence of MAO-B mRNA. The results indicate that both total protein/g fresh weight and MAO-A protein/g fresh weight were approximately 40 per cent lower in pre-eclamptic than in normotensive placentae, but that there was no statistical difference in the expression of MAO-A mRNA in relation to GAPDH or actin mRNA or in MAO-A protein/mg total protein. However, MAO-A activity/g fresh weight was significantly reduced in pre-eclamptic placentae, in agreement with previous findings. This was found to be due to a 60 per cent reduction (P< 0.05) in the catalytic turnover (activity/molecule) of the enzyme. This study has therefore clearly shown that the expression of placental MAO-A specific mRNA and MAO-A protein are not specifically affected in pre-eclampsia, but that the catalytic efficiency of the expressed MAO-A enzyme in pre-eclamptic placentae is greatly reduced. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945082     DOI: 10.1053/plac.2001.0770

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  9 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

Authors:  Huiping Zhang; Graeme N Smith; Xudong Liu; Jeanette J A Holden
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

3.  Serotonin homeostasis in the materno-foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta.

Authors:  Rona Karahoda; Hana Horackova; Petr Kastner; Andreas Matthios; Lukas Cerveny; Radim Kucera; Marian Kacerovsky; Jurjen Duintjer Tebbens; Alexandre Bonnin; Cilia Abad; Frantisek Staud
Journal:  Acta Physiol (Oxf)       Date:  2020-05-18       Impact factor: 6.311

Review 4.  Drugs of abuse and human placenta.

Authors:  Vadivel Ganapathy
Journal:  Life Sci       Date:  2010-10-16       Impact factor: 5.037

Review 5.  Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Authors:  Ankit Balhara; Aditya R Kumar; Jashvant D Unadkat
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

6.  Placental oxidative stress and monoamine oxidase expression are increased in severe preeclampsia: a pilot study.

Authors:  Anca M Bînă; Adrian Sturza; Ioana Iancu; Adelina G Mocanu; Elena Bernad; Daniela V Chiriac; Claudia Borza; Marius L Craina; Zoran L Popa; Danina M Muntean; Octavian M Crețu
Journal:  Mol Cell Biochem       Date:  2022-06-13       Impact factor: 3.842

Review 7.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

8.  Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development†.

Authors:  Cheryl S Rosenfeld
Journal:  Biol Reprod       Date:  2020-03-13       Impact factor: 4.285

Review 9.  The Serotonin-Immune Axis in Preeclampsia.

Authors:  Serena Gumusoglu; Sabrina Scroggins; Julie Vignato; Donna Santillan; Mark Santillan
Journal:  Curr Hypertens Rep       Date:  2021-08-05       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.